Background illustration for clinical trials search

Macular Degeneration Clinical Trials

Browse 119 macular degeneration clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
FeaturedActive & Responsive

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

for
Geographic Atrophy
Location: Philadelphia PA, Baltimore MD, Durham NC, Lynchburg VA,
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT05626114

Phase2, Recruiting
Featured

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: Portland ME, Little Silver NJ, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase3, Recruiting
Featured

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for
Neovascular Age-related Macular Degeneration
Location: Hickory NC, Austin TX
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT04853251

Recruiting
Active & Responsive

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Carmel IN, La Crosse WI, Dallas TX, Reno NV
Sponsor: Complement Therapeutics

Sex: All

Age: 55+

Code: NCT07392255

Phase1, Phase2, Recruiting
Active & Responsive

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Bethlehem PA, Durham NC, Oak Forest IL, La Crosse WI,
Sponsor: Complement Therapeutics

Sex: All

Age: 55+

Code: NCT07144137

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

for
Age-Related Macular Degeneration
Location: Boston MA, Philadelphia PA, Atlanta GA, Ann Arbor MI,
Sponsor: Astellas Institute for Regenerative Medicine

Sex: All

Age: 50+

Code: NCT03178149

Phase1, Recruiting
Active & Responsive

Lutein, Zeaxathin, and Fish Oil Supplementation

for
Cognitive Performance, Age-Related Macular Degeneration,
Location: College Station TX
Sponsor: Texas A&M University

Sex: All

Age: 18 - 45

Code: NCT06489873

Recruiting
Active & Responsive

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

for
Age-Related Macular Degeneration
Location: Erie PA, Madison WI, Fargo ND, The Woodlands TX,
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 50+

Code: NCT06924021

Recruiting
Active & Responsive

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

for
Age-Related Macular Degeneration, Geographic Atrophy
Location: Lawrence MA, Eatontown NJ, Sarasota FL, Cleveland OH,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT05438732

Recruiting
Active & Responsive

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

for
Stargardt Disease, Stargardt Disease 1, Cone Rod Dystrophy,
Location: Boston MA, Baltimore MD, Gainesville FL, Ann Arbor MI,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 5+

Code: NCT06445322

Recruiting
Active & Responsive

OCT Angiography in Wet AMD

for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 50 - 70+

Code: NCT02253030

Recruiting
Active & Responsive

Effects of Goji vs. Fiber on Macular Degeneration

for
Age-Related Macular Degeneration
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 65 - 70+

Code: NCT06237127

Recruiting
Active & Responsive

Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.

for
Macular Degeneration
Location: Cleveland OH
Sponsor: Scott Raymond

Sex: All

Age: 50 - 70+

Code: NCT07798323

Recruiting
Active & Responsive

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

for
Age-Related Macular Degeneration,
Location: Manchester CT, Beachwood OH, Lemont IL, Tyler TX,
Sponsor: i-Lumen Scientific AUS PTY LTD

Sex: All

Age: 60+

Code: NCT06662162

Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase2, Phase3, Recruiting
Active & Responsive

Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

for
Dry Age-related Macular Degeneration
Location: McAllen TX
Sponsor: Ocugen

Sex: All

Age: 55+

Code: NCT07770828

Phase3, Recruiting
Active & Responsive

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

for
Low Vision, Central Visual Impairment, Macular Degeneration
Location: Boston MA
Sponsor: New England College of Optometry

Sex: All

Age: 14+

Code: NCT07577219

Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Hauppauge NY, Cherry Hill NJ, Bethlehem PA,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07440225

Phase2, Phase3, Recruiting
Active & Responsive

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Boston MA, New York NY, Toms River NJ, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 50+

Code: NCT07441642

Phase2, Recruiting
Active & Responsive

Study of ALK-001 on the Progression of Stargardt Disease

for
Stargardt Disease
Location: Norfolk VA, Fairfax VA, Pittsburgh PA, Erie PA,
Sponsor: Alkeus Pharmaceuticals, Inc.

Sex: All

Age: 8 - 45

Code: NCT07419334

Phase3, Recruiting